Merck & Co. (Non-US Commercial Rights of Aggrastat) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Merck & Co. (Non-US Commercial Rights of Aggrastat) General Information
Description
Commercial rights of a cardiovascular product outside of the United States. The drug is used to treat acute coronary syndrome in patients who are managed medically and those undergoing percutaneous transluminal coronary angioplasty (PTCA).
Contact Information
Corporate Office
- Kenilworth, NJ
- United States
Corporate Office
- Kenilworth, NJ
- United States
Merck & Co. (Non-US Commercial Rights of Aggrastat) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Merck & Co. (Non-US Commercial Rights of Aggrastat) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Merck & Co. (Non-US Commercial Rights of Aggrastat) FAQs
-
Where is Merck & Co. (Non-US Commercial Rights of Aggrastat) headquartered?
Merck & Co. (Non-US Commercial Rights of Aggrastat) is headquartered in Kenilworth, NJ.
-
What industry is Merck & Co. (Non-US Commercial Rights of Aggrastat) in?
Merck & Co. (Non-US Commercial Rights of Aggrastat)’s primary industry is Buildings and Property.
-
Is Merck & Co. (Non-US Commercial Rights of Aggrastat) a private or public company?
Merck & Co. (Non-US Commercial Rights of Aggrastat) is a Private company.
-
What is Merck & Co. (Non-US Commercial Rights of Aggrastat)’s current revenue?
The current revenue for Merck & Co. (Non-US Commercial Rights of Aggrastat) is .
-
Who are Merck & Co. (Non-US Commercial Rights of Aggrastat)’s investors?
Merck & Co. has invested in Merck & Co. (Non-US Commercial Rights of Aggrastat).
-
When was Merck & Co. (Non-US Commercial Rights of Aggrastat) acquired?
Merck & Co. (Non-US Commercial Rights of Aggrastat) was acquired on 30-Jan-2008.
-
Who acquired Merck & Co. (Non-US Commercial Rights of Aggrastat)?
Merck & Co. (Non-US Commercial Rights of Aggrastat) was acquired by Iroko Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process